| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Rodman & Renshaw initiates Karyopharm stock with buy rating | ||
| Mo | Jefferies initiates U.S. Physical Therapy stock with buy rating on growth outlook | ||
| Mo | Jones Trading reiterates iBio stock rating on obesity drug data | ||
| Mo | RBC Capital lowers Ardent Health stock price target on revised estimates | ||
| Mo | Truist raises Essential Properties stock price target on investment outlook | ||
| Mo | Stifel reiterates Chipotle stock rating on marketing, equipment plans | ||
| Mo | Barclays reiterates Jazz Pharmaceuticals stock rating on CNS strength | ||
| Mo | Stifel reiterates Chipotle stock rating citing efficiency gains | ||
| Mo | Morgan Stanley says Lam Research and Applied Materials see extended demand visibility | ||
| Mo | Cohen & Steers reports assets under management at $98.4 billion | ||
| Mo | Equifax cuts VantageScore 4.0 mortgage credit score price to $1 | ||
| Mo | Essential Properties declares $0.31 quarterly dividend | ||
| Mo | Planet Fitness names Tom Fitzgerald interim CFO | ||
| Mo | Transco launches exchange offer for $1.7 billion in senior notes | ||
| Mo | OPAL Fuels closes $180M preferred stock facility with Fortistar | ||
| Mo | Jefferies reaffirms Signet Jewelers stock rating on holiday strength | ||
| Mo | Evercore ISI reiterates Kirby stock rating on Jones Act waiver talk | ||
| Mo | StepStone Group authorizes $100 million stock buyback program | ||
| Mo | Prothena earns $50M milestone from Novo Nordisk for drug trial | ||
| Mo | Myomo enters network agreement with Elevance Health plans | ||
| Mo | Vertex's povetacicept meets primary endpoint in IgAN trial | ||
| Mo | Shift4 announces executive changes, new international president | ||
| Mo | Nu Skin promotes Chayce Clark to chief operating officer | ||
| Mo | AEON Biopharma names John Bencich as chief financial officer | ||
| Mo | Transcat names Jaime Irick as CEO effective March 29 |